Prosecution Insights
Last updated: April 19, 2026

Paracrine Therapeutics AB

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18121075 TREATMENT OF ER-NEGATIVE BREAST CANCER WITH AN PDGF-CC INHIBITOR AND AN ANTI-ESTROGEN NICKOL, GARY B 1643 Non-Final OA Mar 14, 2023
17739457 METHODS AND COMPOSITIONS FOR PDGF-CC INHIBITION ALLEN, MARIANNE P 1647 Final Rejection May 09, 2022

Managing Paracrine Therapeutics AB's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month